SynthesisBreast (Edinburgh, Scotland)2020

Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis.

Paul Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.